Notes
J . Org. Chem., Vol. 64, No. 19, 1999 7241
+ Na)+, 709.8 (M + K)+. Anal. Calcd for C47H46N2O2‚2H2O: C,
79.86; H, 7.13; N, 3.96. Found: C, 80.29; H, 6.87; N, 3.91.
10b. Colorless solid. Yield: 24 mg (3.6%). Mp: 285 °C. Rf 0.31
(CH2Cl2/ethyl acetate 25:1). 1H NMR (250 MHz, CDCl3) δ 1.23
(18H, s), 1.38 (9H, s), 1.50 (4H, br), 1.60 (8H, br), 1.88 (24H, s),
2.24 (8H, br), 6.31 (2H, d, J ) 8.3 Hz), 6.77 (2H, d, J ) 8.6 Hz),
6.85-6.95 (12H, m), 7.15-7.30 (17H, m), 7.45 (2H, s), 7.61 (1H,
s), 7.61 (1H, t, J ) 7.7 Hz), 7.73 (4H, s, NH), 8.02 (1H, s), 8.12
(2H, d, J ) 7.7 Hz), 8.18 (3H, s). 13C NMR (62.9 MHz, CDCl3) δ
18.56 (CH3), 18.59 (CH3), 22.96 (CH2), 26.28 (CH2), 31.22 (CH3),
31.33 (CH3), 34.94 (Cq), 35.27 (Cq), 35.65 (CH2), 36.21 (CH2),
45.35 (Cq), 64.56 (Cq), 119.50 (CH), 121.16 (CH), 122.54 (CH),
122.97 (CH), 125.64 (CH), 125.83 (Cq), 125.98 (CH), 126.19 (CH),
126.76 (CH), 126.85 (CH), 127.24 (CH), 127.52 (CH), 127.65
(CH), 128.76 (CH), 129.80 (CH), 130.95 (CH), 131.07 (CH),
131.19 (Cq), 131.27 (Cq), 131.52 (CH), 131.85 (Cq), 132.18 (CH),
134.55 (Cq), 134.83 (Cq), 134.94 (Cq), 141.69 (Cq), 145.05 (Cq),
146.32 (Cq), 146.56 (Cq), 148.20 (Cq), 148.45 (Cq), 151.87 (Cq),
153.76 (Cq), 165.58 (CO), 166.08 (CO), 166.69 (CO), 168.30 (CO).
MALDI-TOFMS (2,5-dihydroxybenzoic acid): 1654.2 (M + Na)+.
Anal. Calcd for C111H117N5O7‚4H2O‚C4H8O2: C, 77.02; H, 7.47;
N, 3.91. Found: C, 77.16; H, 7.30; N, 3.67.
1.92 (24H, s), 2.30 (8H, br), 6.98 (16H, br), 7.1-7.3 (30H, m),
7.69 (1H, t, J ) 7.7 Hz), 8.07 (2H, d, J ) 7.7 Hz), 8.09 (2H, s),
8.46 (1H, s), 8.57 (1H, s), 8.60 (2H, s, NH), 9.06 (2H, s, NH),
9.19 (2H, s, NH). 13C NMR (62.9 MHz, DMSO-d6) δ 18.70 (CH3),
22.64 (CH2), 25.88 (CH2), 27.00 (CH2), 29.03 (CH2), 31.02 (CH3),
34.59 (CH2), 34.86 (Cq), 38.56 (Cq), 64.08 (Cq), 120.98 (CH),
121.01 (CH), 125.49 (CH), 125.97 (CH), 127.70 (CH), 129.39
(CH), 130.39 (CH), 130.84 (CH), 132.10 (Cq), 134.16 (Cq), 134.45
(Cq), 135.66 (Cq), 135.75 (Cq), 142.11 (Cq), 146.45 (Cq), 152.31
(Cq), 164.85 (CO), 176.86 (CO). MALDI-TOFMS (2,5-dihydroxy-
benzoic acid): 1794.6 (M + H)+, 1816.6 (M + Na)+, 1833.7 (M +
K)+. Anal. Calcd for C124H124N6O6‚5H2O‚C4H8O2: C, 77.94; H,
7.26; N, 4.26. Found: C, 77.50; H, 7.02; N, 4.14.
N,N′-(4-Tr itylph en yl)bicyclo[2.2.2]octan e-1,4-dicar boxyl-
a m id e (fr ee a xle of 12). Colorless solid. Yield: 52 mg (15%).
Mp: >320 °C. Rf 0.84 (CH2Cl2/ethyl acetate 25:1). 1H NMR (250
MHz, DMSO-d6/CDCl3 2:1) δ 1.82 (12H, s), 7.02 and 7.50 (8H,
AA′BB′, J ) 8.1 Hz), 7.1-7.25 (30H, m), 9.04 (2H, br, NH).
MALDI-TOFMS (2,5-dihydroxybenzoic acid): 833.7 (M + H)+,
855.5 (M + Na)+, 872.5 (M + K)+. Anal. Calcd for C60H52N2O2‚
3H2O: C, 81.24; H, 6.59; N, 3.16. Found: C, 80.88; H, 6.32; N,
2.99.
Syn th esis of Rota xa n e 13. A 384 mg (0.4 mmol) portion of
tetralactam 1a and 62 mg (0.4 mmol) of succinyl dichloride are
dissolved in 200 mL of CH2Cl2 and cooled to -5 °C. A solution
of 268 mg (0.8 mmol) of 4-tritylaniline (6a ) and 12 drops of
triethylamine in 200 mL of CH2Cl2 is added dropwise during 4
h. After 24 h of additional stirring the solvent is evaporated,
and the residue is purified by column chromatography [SiO2,
CH2Cl2/ethyl acetate (15:1)] to yield the rotaxane and the free
axle.
4-Tr itylp h en yl 4-(3,5-Di-ter t-bu tylben za m id o)ben zoa te
(fr ee a xle of 10b). Colorless solid. Yield: 147 mg (55%). Mp:
250 °C. Rf 0.91 (CH2Cl2/ethyl acetate 25:1). 1H NMR (250 MHz,
3
CDCl3) δ 1.36 (9H, s), 7.10 and 7.27 (4H, AA′BB′, J ) 8.8 Hz),
7.15-7.25 (15H, m), 7.64 (1H, t, J ) 1.8 Hz), 7.70 (2H, d, J )
1.8 Hz), 7.81 and 8.18 (4H, AA′BB′, 3J ) 8.9 Hz), 8.15 (1H, br,
NH).13C NMR (62.9 MHz, CDCl3) δ 31.29 (CH3), 34.96 (Cq), 64.54
(Cq), 119.43 (CH), 120.49 (CH), 121.32 (CH), 124.64 (Cq), 125.94
(CH), 126.39 (CH), 127.49 (CH), 131.02 (CH), 131.35 (CH),
132.10 (CH), 134.14 (Cq), 143.11 (Cq), 144.33 (Cq), 146.51 (Cq),
148.76 (Cq), 151.55 (Cq), 164.70 (CO), 176.21 (CO). MALDI-
TOFMS (2,5-dihydroxybenzoic acid): 672.8 (M + H)+, 694.8 (M
+ Na)+. Anal. Calcd for C47H45NO3: C, 84.02; H, 6.75; N, 2.08.
Found: C, 83.56; H, 6.73; N, 1.97.
13. Colorless solid. Yield: 157 mg (23%). Mp: >340 °C. Rf 0.19
1
(CH2Cl2/ethyl acetate 20:1). H NMR (250 MHz, CDCl3/DMSO-
d6 1:1) δ 1.27 (9H, s), 1.49 (4H, br), 1.57 (8H, br), 1.83 and 1.84
(28H, 2s + br), 2.28 (8H, br), 6.77 and 6.83 (8H, AA′BB′, 3J )
8.9 Hz), 6.88 (8H, s), 7.05-7.2 (30H, m), 7.52 (1H, t, J ) 7.7
Hz), 8.00 (2H, d, J ) 7.7 Hz), 8.06 (2H, s), 8.21 (1H, s), 8.32
Syn th esis of Rota xa n es 11 a n d 12. A 384 mg (0.4 mmol)
portion of tetralactam 1a and 0.4 mmol of adamantane-1,3-
dicarbonyl chloride or bicyclo[2.2.2]octane-1,4-dicarbonyl chloride
are dissolved in 100 mL of CH2Cl2 and cooled to -5 °C. A solution
of 268 mg (0.8 mmol) of 4-tritylaniline (6a ) and 12 drops of
triethylamine in 100 mL of CH2Cl2 is added dropwise during 4
h. After 2 h of additional stirring the solvent is evaporated, and
the residue is purified by column chromatography [SiO2, CH2-
Cl2/ethyl acetate (25:1)] to yield the rotaxanes and free axles.
11. Colorless solid. Yield: 320 mg (44%). Mp: 260 °C. Rf 0.32
(CH2Cl2/ethyl acetate 25:1). 1H NMR (250 MHz, DMSO-d6) δ 0.25
(2H, br), 1.2 (2H, br), 1.3 (8H, br), 1.36 (9H, s), 1.4-1.6 (14H,
br), 1.91 (12H, s), 1.95 (12H, s), 2.29 (8H, br), 6.95-7.35 (46H,
m), 7.67 (1H, t, J ) 7.7 Hz), 8.08 (4H, s+d, overlapped), 8.53
(1H, s), 8.62 (1H, s), 8.71 (2H, s, NH), 9.18 (2H, br, NH), 9.30
(2H, br, NH). 13C NMR (62.9 MHz, CDCl3/CD3OD 5:1) δ 18.40
(CH3), 18.48 (CH3), 22.59 (CH2), 26.07 (CH2), 27.66 (CH), 30.84
(CH3), 34.78 (CH2), 34.94 (Cq), 36.99 (CH2), 38.78 (CH2), 41.02
(Cq), 44.64 (Cq), 64.31 (Cq), 120.08 (CH), 125.65 (CH), 125.72
(CH), 127.25 (CH), 128.45 (CH), 129.15 (CH), 130.74 (CH),
130.94 (CH), 130.98 (CH), 131.01 (CH), 133.42 (C), 133.91 (Cq),
134.76 (Cq), 134.87 (Cq), 142.97 (Cq), 146.39 (Cq), 147.42 (Cq),
147.61 (Cq), 152.95 (Cq), 166.06 (CO), 166.27 (CO), 176.81 (CO).
MALDI-TOFMS (2,5-dihydroxybenzoic acid): 1821.9 (M + H)+,
1843.9 (M + Na)+. Anal. Calcd for C126H126N6O6‚H2O‚C4H8O2:
C, 81.05; H, 7.12; N, 4.36. Found: C, 80.79; H, 7.01; N, 4.42.
N ,N ′-(4-T r i t y lp h e n y l)a d a m a n t a n e -1,3-d i c a r b o x y l-
a m id e (fr ee a xle of 11). Colorless solid. Yield: 42 mg (12%).
Mp: >320 °C. Rf 0.81 (CH2Cl2/ethyl acetate 25:1). 1H NMR (250
MHz, DMSO-d6) δ 1.67 (2H, br), 1.87 (8H, br), 2.04 (2H, br),
2.16 (2H, br), 7.02 and 7.55 (8H, AA′BB′), 7.1-7.3 (30H, m), 9.23
(2H, s, NH). MALDI-TOFMS (2,5-dihydroxybenzoic acid): 859.4
(M + H)+, 881.4 (M + Na)+. Anal. Calcd for C62H54N2O2‚H2O:
C, 84.90; H, 6.43; N, 3.19. Found: C, 84.90; H, 6.14; N, 3.06.
12. Colorless solid. Yield: 180 mg (25%). Mp: >320 °C. Rf 0.44
(CH2Cl2/ethyl acetate 25:1). 1H NMR (250 MHz, DMSO-d6/CDCl3
2:1) δ 1.01 (12H, s), 1.36 (9H, s), 1.46 (4H, br), 1.53 (8H, br),
(2H, s, NH), 8.40 (1H, s), 9.16 (2H, s, NH), 9.20 (2H, s, NH). 13
C
NMR (62.9 MHz, DMSO-d6/CDCl3 2:1) δ 18.19 (CH3), 18.23
(CH3), 22.53 (CH2), 25.83 (CH2), 30.19 (CH2), 30.86 (CH3), 34.64
(CH2), 44.41 (Cq), 63.85 (Cq), 118.41 (CH), 121.74 (CH), 125.37
(CH), 125.63 (CH), 127.22 (CH), 128.70 (CH), 130.13 (CH),
130.33 (CH), 130.52 (CH), 132.07 (Cq), 132.19 (Cq), 134.00 (Cq),
134.24 (Cq), 134.75 (Cq), 135.75 (Cq), 141.15 (Cq), 146.21 (Cq),
146.84 (Cq), 147.00 (Cq), 151.76 (Cq), 164.55 (CO), 164.92 (CO),
170.23 (CO). MALDI-TOFMS (2,5-dihydroxybenzoic acid): 1736.6
(M + Na)+. FABMS (3-nitrobenzyl alcohol): 1713.0 (M + H)+.
Anal. Calcd for C118H116N6O6‚H2O‚C4H8O2: C, 80.50; H, 6.98; N,
4.62. Found: C, 80.29; H, 6.80; N, 4.76.
N,N′-(4-Tr itylp h en yl)su ccin a m id e (fr ee a xle of 13). Col-
orless solid. Yield: 96 mg (32%). Mp: 273 °C. Rf 0.33 (CH2Cl2/
1
ethyl acetate 20:1). H NMR (250 MHz, CDCl3/DMSO-d6 1:1) δ
2.60 (4H, s), 7.00 and 7.43 (8H, AA′BB′, 3J ) 8.7 Hz), 7.1-7.2
(15H, m), 9.82 (2H, s, NH). FABMS (3-nitrobenzyl alcohol): 753.4
(M + H)+. Anal. Calcd for C54H44N2O2‚0.5H2O: C, 85.12; H, 5.95;
N, 3.68. Found: C, 85.16; H, 5.89; N, 3.80.
Syn th esis of Rota xa n e 14. A mixture of 384 mg (0.4 mmol)
of tetralactam 1a and 159 mg (0.4 mmol) of di-N-succinimidyl
sebacinate17 in 100 mL of CH2Cl2 is added dropwise during 4 h
to a refluxing solution of 268 mg (0.8 mmol) of 4-tritylaniline
(6a ) and 98 mg (0.8 mmol) of N,N-dimethylaminopyridin in 100
mL of CH2Cl2. After 24
h of additional stirring at room
temperature the solvent is evaporated, and the residue is
purified by column chromatography [SiO2, CH2Cl2/ethyl acetate
(20:1)] to yield the rotaxane and the free axle.
14. Colorless solid. Yield: 80 mg (11%). Mp: 312 °C. Rf 0.35
(CH2Cl2/ethyl acetate 20:1).1H NMR (250 MHz, DMSO-d6) δ 0.76
(4H, br), 1.09 (4H, br), 1.32 (9H, s), 1.46 (4H, br), 1.55 (8H, br),
1.69 (4H, br t), 1.95 (24H, s), 2.29 (8H, br), 6.9-7.3 (46H, m),
7.61 (1H, t, J ) 7.7 Hz), 8.01 (2H, d, J ) 7.7 Hz), 8.04 (2H, s),
8.37 (1H, s), 8.50 (1H, s), 9.16 (2H, s, NH), 9.21 (2H, s, NH),
9.41 (2H, s, NH). 13C NMR (62.9 MHz, DMSO-d6, 50 °C) δ 18.27
(CH3), 22.54 (CH2), 24.38 (CH2), 25.76 (CH2), 28.32 (CH2), 30.83
(CH3), 34.62 (CH2), 35.51 (CH2), 44.41 (Cq), 63.87 (Cq), 118.69
(CH), 125.44 (CH), 125.72 (CH), 126.92 (CH), 127.39 (CH),
130.23 (CH), 130.41 (CH), 132.13 (Cq), 134.23 (Cq), 134.29 (Cq),
134.36 (Cq), 134.54 (Cq), 136.27 (Cq), 141.01 (Cq), 146.28 (Cq),
(17) Kondo, M.; Shimizu, Y.; Murata, A. Agric. Biol. Chem. 1982,
46, 913-918.